Counterfeits quantified

$75 billion. That's an estimate of the revenue generated in the 2010 counterfeit drug market, according to The Center for Medicine in the Public Interest. The center's president, former FDA associate commissioner Peter Pitts, bases the figure on government information. He projects growth of 20% annually in the coming years. News

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.